Detalles de la búsqueda
1.
Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial.
J Infect Chemother
; 29(9): 869-874, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37178973
2.
Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19.
J Infect Chemother
; 27(6): 808-813, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33531292
3.
High diagnostic accuracy of quantitative SARS-CoV-2 spike-binding-IgG assay and correlation with in vitro viral neutralizing activity.
Heliyon
; 10(2): e24513, 2024 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38304834
4.
Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved.
Heliyon
; 9(10): e20568, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37842585
5.
Talar Middle Facet Fracture: A Report of 2 Cases.
Foot Ankle Orthop
; 7(3): 24730114221115684, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35959143
6.
Risk factors for mental health of Technical Intern Trainees from the Philippines / 国際保健医療
Journal of International Health
; : 303-312, 2018.
Artículo
en Japonés
| WPRIM | ID: wpr-738252
7.
Risk factors for mental health of Technical Intern Trainees from the Philippines / 国際保健医療
Journal of International Health
; : 303-312, 2018.
Artículo
en Japonés
| WPRIM | ID: wpr-688903
8.
The Number of Lives Saved and Quality-adjusted Life Years Prolonged by Ticlopidine Hydrochloride over the Past 20 years in Japan / General Medicine
General Medicine
; : 61-70, 2006.
Artículo
en Inglés
| WPRIM | ID: wpr-376341
9.
Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21260744
10.
SARS-CoV-2-neutralizing humoral IgA response occurs earlier but modest and diminishes faster compared to IgG response.
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-495422
11.
Highly-Neutralizing COVID-19-Convalescent-Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-450453
12.
SARS-CoV-2 breakthrough infection during the Delta-dominant epidemic and neutralizing antibodies against Omicron in comparison with the third dose of BNT162b2: a matched analysis
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22276682
13.
Association study of HLA with the kinetics of SARS-CoV-2 spike specific IgG antibody responses to BNT162b2 mRNA vaccine
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22270285
14.
SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with BNT162b2
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21265632
15.
COVID-19 breakthrough infections and pre-infection neutralizing antibody
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21265301
16.
Neutralizing antibodies following three doses of BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron predominant wave
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-22280009
17.
Correlates of Neutralizing/SARS-CoV-2-S1-binding Antibody Response with Adverse Effects and Immune Kinetics in BNT162b2-Vaccinated Individuals
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21261237
Resultados
1 -
17
de 17
1
Próxima >
>>